Hypertension in the Neonate
نویسندگان
چکیده
منابع مشابه
Pulmonary Hypertension in the Neonate
Persistent pulmonary hypertensin of the newborn (PPHN), a major clinical problem in the neonatal intensive care unit, can contribute significantly to morbidity and mortality in both term and preterm infants. Hypoxemic respiratory failure or PPHN can place newborns at risk for death, neurologic injury, and other morbidities. PPHN is categorized into parenchymal lung disease (meconium aspiration ...
متن کاملPersistent pulmonary hypertension in the neonate.
Respiratory failure is the leading cause of death in the neonatal period. The anatomic and functional basis for this, particularly in full-term infants, most often is persistent pulmonary hypertension of the neonate (PPHN). This condition is reversible but can cause very severe and unrelenting respiratory failure and ultimate death when uncontrolled. Recent technologic advances have expanded th...
متن کاملDevelopmental hypertension, nephrogenesis, and mother's milk: programming the neonate.
C ompelling epidemiologic and experimental evidence indicates that early-life experiences shape risk for disease in later life. Infants who are born smaller, reflecting a slower growth trajectory in utero, experience higher incidences of hypertension, obesity, diabetes, and renal disease as adults (1). Birth weight is a crude surrogate for the broad spectrum of specific adverse events that may ...
متن کاملPaediatrics: Sildenafil in the treatment of pulmonary hypertension in the neonate
Pulmonary hypertension refers to a group of diseases that is characterised by high pressure in the pulmonary artery, and pulmonary vascular resistance. Persistent pulmonary hypertension in the newborn is a condition in which the pulmonary artery pressure does not decrease after birth. It may occur in as many as 6.8 in 1 000 live births. Phosphodiesterase type 5 (PDE5) is the predominant phospho...
متن کاملAn update on sildenafil in the treatment of pulmonary arterial hypertension in the neonate
Pulmonary arterial hypertension (PAH) refers to a group of diseases that are characterised by high pressure in the pulmonary artery and by pulmonary vascular resistance. Persistent PAH in the newborn is a condition whereby the pulmonary artery pressure does not decrease after birth, and may occur in as many as 6.8 in 1 000 live births. Phosphodiesterase type 5 (PDE-5) is the predominant PDE iso...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1985
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-198510000-00252